BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36581888)

  • 21. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
    Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
    Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome.
    Kedlaya R; Veera S; Horan DJ; Moss RE; Ayturk UM; Jacobsen CM; Bowen ME; Paszty C; Warman ML; Robling AG
    Sci Transl Med; 2013 Nov; 5(211):211ra158. PubMed ID: 24225945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.
    Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation.
    You L; Chen L; Pan L; Peng Y; Chen J
    Cell Physiol Biochem; 2018; 48(3):1030-1040. PubMed ID: 30041240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
    Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM
    Breast Cancer Res; 2014 Dec; 16(6):458. PubMed ID: 25439669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
    Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
    Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Albiol L; Cilla M; Pflanz D; Kramer I; Kneissel M; Duda GN; Willie BM; Checa S
    J R Soc Interface; 2018 Apr; 15(141):. PubMed ID: 29669893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
    Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
    Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice.
    Koide M; Yamashita T; Nakamura K; Yasuda H; Udagawa N; Kobayashi Y
    Bone; 2022 Jul; 160():116401. PubMed ID: 35381389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.
    Dunn LK; Mohammad KS; Fournier PG; McKenna CR; Davis HW; Niewolna M; Peng XH; Chirgwin JM; Guise TA
    PLoS One; 2009 Sep; 4(9):e6896. PubMed ID: 19727403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerostin vaccination mitigates estrogen deficiency induction of bone mass loss and microstructure deterioration.
    Wang FS; Wu RW; Lain WS; Tsai TC; Chen YS; Sun YC; Ke HJ; Li JC; Hwang J; Ko JY
    Bone; 2018 Jul; 112():24-34. PubMed ID: 29653294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.
    Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N
    J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
    Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
    J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
    Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
    Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis.
    Krishna SM; Seto SW; Jose RJ; Li J; Morton SK; Biros E; Wang Y; Nsengiyumva V; Lindeman JH; Loots GG; Rush CM; Craig JM; Golledge J
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):553-566. PubMed ID: 28062506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-κB/bone remodeling factors signaling.
    Xu Y; Zhang S; Liao X; Li M; Chen S; Li X; Wu X; Yang M; Tang M; Hu Y; Li Z; Yu R; Huang M; Song L; Li J
    Mol Cancer; 2021 Jul; 20(1):98. PubMed ID: 34325714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.
    Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M
    Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.
    Yamaguchi M
    Mol Cell Biochem; 2016 Oct; 421(1-2):193-203. PubMed ID: 27573001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential donor-dependent regulative effects of endogenous sclerostin expression and mineralization potential in primary human PDL cells in vitro.
    Knaup I; Bastian A; Mack P; Sasula MJ; Niederau C; Roth C; Jankowski J; Wolf M
    Ann Anat; 2022 Oct; 244():151980. PubMed ID: 35787444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
    Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
    J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.